May 13, 2015 | BioLight Life Sciences, a firm that invests in, manages and commercializes biomedical innovations in ophthalmology and cancer diagnostics, announced that it completed an upsized private placement of $6.6 million. The private placement took place as part of a strategic partnership with Rock-One International Holdings. BioLight announced the strategic partnership on April 2, 2015 and is headquartered in Tel Aviv.
Related posts
Israeli AI Safety Tool Among TIME’S Best Inventions For 2024
October 31, 2024
TAU Team Discovers Mechanism To Eliminate Cancerous Tumors
October 30, 2024
Ashdod Port Investing In Startups As Part Of Innovation Strategy
October 29, 2024
BGU Develops Fast Fact Checking Via News Sources Not People
October 28, 2024
Facebook comments